These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6531397)

  • 1. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin.
    Kata M; Lukács M
    Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation and investigation of products containing metronidazole and beta-cyclodextrin].
    Kata M; Antal A
    Acta Pharm Hung; 1984 May; 54(3):116-22. PubMed ID: 6464773
    [No Abstract]   [Full Text] [Related]  

  • 3. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of beta-cyclodextrin during direct pressing of tablets].
    Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B
    Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
    Krajnyák J; Rácz I; Dávid A; Szejtli J
    Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of some benzothiadiazine diuretics with beta-cyclodextrin.
    Abdel-Rahman SI; el-Sayed AM
    Acta Pharm Hung; 1990 May; 60(2-3):69-75. PubMed ID: 2386074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spray embedding of vinpocetin with beta-cyclodextrin].
    Kata M; György E
    Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
    Hegde RP; Rhodes CT
    Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
    [No Abstract]   [Full Text] [Related]  

  • 16. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch.
    Mourtzinos I; Kalogeropoulos N; Papadakis SE; Konstantinou K; Karathanos VT
    J Food Sci; 2008 Jan; 73(1):S89-94. PubMed ID: 18211376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wettability of cyclodextrin complexes.
    Szente L; Szejtli J
    Acta Pharm Hung; 1987 Mar; 57(1-2):73-6. PubMed ID: 3591344
    [No Abstract]   [Full Text] [Related]  

  • 20. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.